Feng Yu Kuo

712 total citations
40 papers, 532 citations indexed

About

Feng Yu Kuo is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Feng Yu Kuo has authored 40 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Feng Yu Kuo's work include Acute Myocardial Infarction Research (16 papers), Coronary Interventions and Diagnostics (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Feng Yu Kuo is often cited by papers focused on Acute Myocardial Infarction Research (16 papers), Coronary Interventions and Diagnostics (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Feng Yu Kuo collaborates with scholars based in Taiwan, Japan and United States. Feng Yu Kuo's co-authors include R. Clark Lantz, Michael Skinner, Mary Pat Knadler, Todd A. Gillespie, Juei‐Tang Cheng, Yingxiao Li, Kai‐Chun Cheng, Zhih‐Cherng Chen, Wei‐Ting Chang and Ming‐Chang Wu and has published in prestigious journals such as Journal of the American College of Cardiology, Scientific Reports and Drug Metabolism and Disposition.

In The Last Decade

Feng Yu Kuo

35 papers receiving 516 citations

Peers

Feng Yu Kuo

CCM

PHARM

SURGE

PHYSI

M.M. Arrebola Spain

Joseph P. Kitzmiller United States

Tuncer Çaycı Türkiye

Judith E. Soberman United States

Ram P. Kapil United States

Chantale Simard Canada

Chandrasekaran Adithan India

Norbert Watzinger Austria

Alison N. Wadworth Switzerland

Miguel A. Zinny United States

M.M. Arrebola Spain

Feng Yu Kuo

105 ×0.6

CCM

62 ×0.6

PHARM

87 ×0.8

SURGE

56 ×0.7

PHYSI

65 ×1.0

Citations per year, relative to Feng Yu Kuo Feng Yu Kuo (= 1×) peers M.M. Arrebola

Countries citing papers authored by Feng Yu Kuo

Since Specialization

Citations

This map shows the geographic impact of Feng Yu Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Yu Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Yu Kuo more than expected).

Fields of papers citing papers by Feng Yu Kuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Yu Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Yu Kuo. The network helps show where Feng Yu Kuo may publish in the future.

Co-authorship network of co-authors of Feng Yu Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Yu Kuo. A scholar is included among the top collaborators of Feng Yu Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Yu Kuo. Feng Yu Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yeh, Ting‐Yu, et al.. (2025). Recombination alters the receptor binding and furin cleavage site in novel bat-borne HKU5-CoV-2 coronavirus. Microbiology Spectrum. 13(10). e0142025–e0142025.

Wu, Yiting, et al.. (2024). Association of scrub typhus with the risk of venous thromboembolism and long-term mortality: a population-based cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 43(5). 905–914.

Lin, Chih‐Yang, Wei‐Chih Sun, Wen‐Chi Chen, et al.. (2024). Entecavir vs. tenofovir disoproxil fumarate in the treatment of chronic hepatitis B patients with severe acute exacerbation. European Journal of Gastroenterology & Hepatology. 36(9). 1113–1118. 1 indexed citations

Huang, Wei‐Chun, et al.. (2023). Long‐term outcomes after stent implantation in very small vessel coronary artery disease. Clinical Cardiology. 46(4). 431–440. 3 indexed citations

Kuo, Feng Yu, Cheng‐Han Lee, Wei‐Ren Lan, et al.. (2022). Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study. Journal of the Formosan Medical Association. 121(9). 1786–1797. 7 indexed citations

Hung, Wan‐Ting, Wei‐Chun Huang, Ying-Chun Jheng, et al.. (2021). The risk of stroke after acute myocardial infarction in patients with and without atrial fibrillation: A nationwide cohort study. Journal of the Chinese Medical Association. 84(12). 1126–1134. 3 indexed citations

Kuo, Feng Yu, Kai‐Chun Cheng, Yingxiao Li, & Juei‐Tang Cheng. (2021). Oral glucose tolerance test in diabetes, the old method revisited. World Journal of Diabetes. 12(6). 786–793. 33 indexed citations

Liu, Ping‐Yen, Cheng‐Huang Su, Feng Yu Kuo, et al.. (2021). Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy. Cardiovascular Intervention and Therapeutics. 37(2). 269–278. 10 indexed citations

Cheng, Chin-Chang, et al.. (2020). Management of Pulmonary Arterial Hypertension Patients with World Health Organization Functional Class II.. PubMed Central. 36(6). 583–587. 1 indexed citations

10.

Kuo, Feng Yu, et al.. (2020). <p>Promotion of Adropin Expression by Hyperglycemia Is Associated with STAT3 Activation in Diabetic Rats</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 2269–2277. 12 indexed citations

11.

Cheng, Kai‐Chun, Wei‐Ting Chang, Feng Yu Kuo, et al.. (2019). TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells. Scientific Reports. 9(1). 3633–3633. 43 indexed citations

12.

Tang, Pei‐Ling, et al.. (2019). Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study. CNS Drugs. 33(2). 175–185. 4 indexed citations

13.

Kuo, Feng Yu, et al.. (2019). <p>GLP-1 mediates the modulating effect of thymoquinone on feeding behaviors in diabetic rats</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 873–881. 6 indexed citations

14.

Cheng, Kai‐Chun, Yingxiao Li, Wei‐Ting Chang, et al.. (2018). Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report. Diabetes Metabolic Syndrome and Obesity. Volume 11. 901–911. 12 indexed citations

15.

Li, Yi‐Heng, Yu-Chen Wang, Yi‐Chih Wang, et al.. (2018). 2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome. Journal of the Formosan Medical Association. 117(9). 766–790. 38 indexed citations

16.

Kuo, Feng Yu, Wei-Chun Huang, Kuan-Rau Chiou, et al.. (2013). The effect of failure mode and effect analysis on reducing percutaneous coronary intervention hospital door-to-balloon time and mortality in ST segment elevation myocardial infarction. BMJ Quality & Safety. 22(8). 626–638. 11 indexed citations

17.

Chung, Chih‐Chung, et al.. (2010). Ratio of early mitral inflow peak velocity to flow propagation velocity predicts training effects of cardiac rehabilitation in patients after acute myocardial infarction. Journal of Rehabilitation Medicine. 42(3). 232–238. 5 indexed citations

18.

Kuo, Feng Yu, et al.. (2008). Recurrent Syncope Due to Carotid Sinus Hypersensitivity and Sick Sinus Syndrome. Journal of the Chinese Medical Association. 71(10). 532–535. 1 indexed citations

19.

Yip, Hon‐Kan, Mien‐Cheng Chen, Hsueh‐Wen Chang, et al.. (2004). Transradial application of percusurge guardwire device during primary percutaneous intervention of infarct‐related artery with high‐burden thrombus formation. Catheterization and Cardiovascular Interventions. 61(4). 503–511. 15 indexed citations

20.

Lantz, R. Clark, et al.. (2003). METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS. Drug Metabolism and Disposition. 31(9). 1142–1150. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact